BRPI0608430A2 - composição adjuvante, processo para preparar a mesma e uso da mesma - Google Patents

composição adjuvante, processo para preparar a mesma e uso da mesma

Info

Publication number
BRPI0608430A2
BRPI0608430A2 BRPI0608430-3A BRPI0608430A BRPI0608430A2 BR PI0608430 A2 BRPI0608430 A2 BR PI0608430A2 BR PI0608430 A BRPI0608430 A BR PI0608430A BR PI0608430 A2 BRPI0608430 A2 BR PI0608430A2
Authority
BR
Brazil
Prior art keywords
adjuvant
adjuvant composition
preparing same
same
iii
Prior art date
Application number
BRPI0608430-3A
Other languages
English (en)
Inventor
Derek Thomas O'hagan
Original Assignee
Novartis Vaccines & Diagnostics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Vaccines & Diagnostics Inc filed Critical Novartis Vaccines & Diagnostics Inc
Publication of BRPI0608430A2 publication Critical patent/BRPI0608430A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

COMPOSIçãO ADJUVANTE, PROCESSO PARA PREPARAR A MESMA E USO DA MESMA. Uma composição imunogênica compreendendo: (i) um antígeno; (ii) um adjuvante fosfato de alumínio; e (iii) um adjuvante monofosforil lipídio A de 3-0-desacilado. Os componentes (ii) e (iii) também podem ser usados como um sistema adjuvante separado. Diversas características das composições são reveladas, incluindo que pelo menos 50% do adjuvante monofosforil lipídio A de 3-0-desacilado devem ser adsorvidos para o adjuvante fosfato de alumínio. A mistura adjuvante é particularmente útil com antígeno de superfície de vírus da hepatite B.
BRPI0608430-3A 2005-02-16 2006-02-16 composição adjuvante, processo para preparar a mesma e uso da mesma BRPI0608430A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US65374105P 2005-02-16 2005-02-16
PCT/GB2006/000557 WO2006087563A2 (en) 2005-02-16 2006-02-16 Adjuvant composition comprising aluminium phosphate and 3d-mpl

Publications (1)

Publication Number Publication Date
BRPI0608430A2 true BRPI0608430A2 (pt) 2009-12-29

Family

ID=36916823

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0608430-3A BRPI0608430A2 (pt) 2005-02-16 2006-02-16 composição adjuvante, processo para preparar a mesma e uso da mesma

Country Status (18)

Country Link
US (1) US20090214592A1 (pt)
EP (1) EP1850871A2 (pt)
JP (1) JP2008530195A (pt)
KR (1) KR20070110513A (pt)
CN (1) CN101146551A (pt)
AP (1) AP2007004151A0 (pt)
AU (1) AU2006215419B2 (pt)
BE (1) BE1016991A6 (pt)
BR (1) BRPI0608430A2 (pt)
CA (1) CA2598079A1 (pt)
EA (1) EA012212B1 (pt)
IL (1) IL185346A0 (pt)
MX (1) MX2007009961A (pt)
NO (1) NO20074679L (pt)
NZ (1) NZ560930A (pt)
SG (1) SG160328A1 (pt)
WO (1) WO2006087563A2 (pt)
ZA (1) ZA200707089B (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0614254A2 (pt) * 2005-08-02 2011-03-15 Novartis Vaccines & Diagnostic redução de interferência entre adjuvantes contendo óleo e antìgenos contendo tensoativos
EP1862176A1 (de) * 2006-05-31 2007-12-05 Rhein Biotech Gesellschaft für neue biotechnologische Prozesse und Produkte mbH Ein Verfahren zur Herstellung einer Impfzusammensetzung
EP1862177A1 (de) * 2006-06-01 2007-12-05 Rhein Biotech Gesellschaft für neue biotechnologische Prozesse und Produkte mbH Ein Verfahren zur Herstellung einer Impfzusammensetzung
SI2097102T1 (sl) * 2006-09-07 2012-09-28 Glaxosmithkline Biolog Sa Kombinirano cepivo, ki ima zmanjšane količine antigena za poliovirus
WO2010099580A1 (en) * 2009-03-05 2010-09-10 Jenny Colleen Mccloskey Treatment of infection
CN102526724B (zh) * 2011-01-14 2015-07-22 四川大学 氢氧化铝凝胶-多糖复合免疫佐剂及其制备方法和用途
EP2726097A4 (en) * 2011-07-01 2015-03-11 Univ California HERPES VIRUS VACCINE AND METHOD OF USE
CN103330936B (zh) * 2013-07-18 2016-01-27 北京民海生物科技有限公司 一种磷酸铝佐剂原位法制备乙肝疫苗的方法
AU2014388299A1 (en) * 2014-03-25 2016-10-20 The Government Of The United States Of America As Represented By The Secretary Of The Army Methods for enhancing the immunostimulation potency of aluminum salt-adsorbed vaccines
MX2022002980A (es) 2019-09-16 2022-04-06 Amgen Inc Metodo para la esterilizacion externa de un dispositivo de suministro de farmacos.
CN120404993B (zh) * 2025-07-03 2025-10-03 成都迈科康生物科技有限公司 一种检测样本中mpl的方法及其相关应用
CN121971597A (zh) * 2026-04-01 2026-05-05 华诺泰生物医药科技(成都)有限公司 一种用于疫苗的as04佐剂组合物及其制备方法和应用

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4707542A (en) * 1983-08-22 1987-11-17 Merck & Co., Inc. Immunogenic HbsAg derived from transformed yeast
GB8508685D0 (en) * 1985-04-03 1985-05-09 Minor P D Peptides
US4912094B1 (en) * 1988-06-29 1994-02-15 Ribi Immunochem Research Inc. Modified lipopolysaccharides and process of preparation
US5084282A (en) * 1990-08-16 1992-01-28 J.C. Steele & Sons Apparatus for forming bricks having a textured edge
ATE84741T1 (de) * 1991-04-26 1993-02-15 Lingl Anlagenbau Verfahren und vorrichtung zum kerben eines tonstrangstueckes.
US6620414B2 (en) * 1992-03-27 2003-09-16 Smithkline Beecham Biologicals (S.A.) Hepatitis vaccines containing 3-0-deacylated monophoshoryl lipid A
KR100310510B1 (ko) * 1993-03-23 2002-07-04 장 스테판느 3-0-탈아세틸화모노포스포릴지질a를함유하는백신조성물
GB9503863D0 (en) * 1995-02-25 1995-04-19 Smithkline Beecham Biolog Vaccine compositions
US6488934B1 (en) * 1995-02-25 2002-12-03 Smithkline Beecham Biologicals S.A. Hepatitis B vaccine
US20010053365A1 (en) * 1995-04-25 2001-12-20 Smithkline Beecham Biologicals S.A. Vaccines
GB9718901D0 (en) * 1997-09-05 1997-11-12 Smithkline Beecham Biolog Vaccine
GB9822714D0 (en) * 1998-10-16 1998-12-09 Smithkline Beecham Sa Vaccines
ES2284287T3 (es) * 1998-10-16 2007-11-01 Glaxosmithkline Biologicals S.A. Sistemas adyuvantes y vacunas.
GB9921146D0 (en) * 1999-09-07 1999-11-10 Smithkline Beecham Biolog Novel composition
US7030094B2 (en) * 2002-02-04 2006-04-18 Corixa Corporation Immunostimulant compositions comprising an aminoalkyl glucosaminide phosphate and QS-21

Also Published As

Publication number Publication date
EP1850871A2 (en) 2007-11-07
ZA200707089B (en) 2008-11-26
MX2007009961A (es) 2008-01-29
AU2006215419A1 (en) 2006-08-24
EA012212B1 (ru) 2009-08-28
BE1016991A6 (fr) 2007-11-06
AP2007004151A0 (en) 2007-10-31
AU2006215419B2 (en) 2012-03-08
SG160328A1 (en) 2010-04-29
EA200701743A1 (ru) 2008-02-28
US20090214592A1 (en) 2009-08-27
NZ560930A (en) 2011-06-30
NO20074679L (no) 2007-09-13
IL185346A0 (en) 2008-02-09
CN101146551A (zh) 2008-03-19
CA2598079A1 (en) 2006-08-24
WO2006087563A2 (en) 2006-08-24
JP2008530195A (ja) 2008-08-07
WO2006087563A3 (en) 2007-03-15
KR20070110513A (ko) 2007-11-19

Similar Documents

Publication Publication Date Title
NO20074679L (no) Adjuvanssammensetning omfattende aluminiumforfat og 3D-MPL
CL2004000293A1 (es) Compuestos derivados de dihidrofenantridin-sulfonamidas sustituidas, sus sales; procedimiento de preparacion; composicion farmaceutica; compuestos intermediarios; y su uso en el tratamiento de la diabetes tipo ii, alzheimer, demencia senil, asma, col
BR0312472A (pt) Prepração de uma composição compreendendo uma mistura de complexos de iscom e uso da dita composição
CL2011003192A1 (es) Acido (2s)-3-(2-fluoro-5-(5-fluoro-1h-pirrolo[2,3-b]piridin-3-il)fenilamino)biciclo[2.2.2]octano-2-carboxilico; metodo para prepararlo; composicion farmaceutica que lo comprende; y su uso en el tratamiento de la influenza; metodo para reducir el virus de la influenza in vitro.
NO20074392L (no) Vaksine
BR0313876A (pt) Uso de uma mistura, composições de combustìvel e de solvente, e, processo para a preparação de uma mistura
BRPI0515218A (pt) composto, composição farmacêutica, método para o tratamento de um mamìfero ou ser humano, método de uso do composto, novos intermediários, uso dos novos intermediários, processo para a preparação de um composto
BRPI0520330A2 (pt) adjuvante a base de ácido polinosìnico-policitidìlico
PT1187629E (pt) Composicao adjuvante que compreende saponina e um oligonucleotido imunoestimulador
CL2007001784A1 (es) Compuestos derivados de benzoxazol de formula la, su composicion farmaceutica, metodo para medir in vivo depositos de amoloide empleando dicha composicion, y uso del compuesto la para preparar un medicamento, y compuesto de formula ib, y su uso como precursor en la preparacion de un compuesto marcado.
BR112015015031A2 (pt) processo de glicoconjugação
CL2011000301A1 (es) Compuestos derivados de purina con actividad inmunomoduladora; composición farmacéutica que los comprende; y uso de ellos en el tratamiento de enfermedades alérgicas, rinitis alérgica, asma, enfermedades infecciosas y cáncer.
NO20005051L (no) Adjuvantsammensetninger
BR0208396A (pt) Ureìa de éster vinìlico
BR0214142A (pt) Derivados e intermediários de n-adamantilmetila como composições farmacêuticas e processos para sua preparação
BRPI0621181A8 (pt) Substâncias imunogênicas que compreendem um adjuvante a base de ácido poliinosínico - ácido policitidílico
PA8575601A1 (es) Procedimiento para su preparacion, medicamentos que comprenden estos compuestos y su uso
BRPI0408819A (pt) formulação, composição combustìvel ou lubrificante, usos de uma formulação e de um solvente, pacote de aditivo, e, processo para a preparação de uma formulação de polialquenamina
BR112023019301A2 (pt) Formulações de vacina de coronavírus
MX2025004075A (es) Vacunas para circovirus porcino tipo 3 (pcv3), y produccion y sus usos
NO20091530L (no) Fenylalkylaminokarbamat preparater
BR112013004925A2 (pt) derivados de éster de fosfonato e métodos de síntese deles.
AR071741A1 (es) Vacunas contra la malaria
BRPI0508555A (pt) composto, uso e composição farmacêutica de combinação
BRPI0712889A8 (pt) composto, processo para a preparação de um composto, composto intermediário, e, composição farmacêutica.

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 9A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2308 DE 31/03/2015.